TNIK in disease: from molecular insights to therapeutic prospects

Apoptosis. 2024 Oct;29(9-10):1361-1376. doi: 10.1007/s10495-024-01987-w. Epub 2024 Jun 9.

Abstract

TRAF2 and NCK interacting kinase (TNIK), a critical interacting protein kinase, is currently receiving wide attention. TNIK is found in various human body organs and tissues and participates in cell motility, proliferation, and differentiation. On the one hand, its aberrant expression is related to the onset and progression of numerous malignant tumors. On the other hand, TNIK is important in neuronal growth, proliferation, differentiation, and synaptic formation. Thus, the novel therapeutic strategies for targeting TNIK offer a promising direction for cancer, neurological or psychotic disorders. Here, we briefly summarized the biological information of TNIK, reviewed the role and regulatory mechanism in cancer and neuropsychiatric diseases, and introduced the research progress of inhibitors targeting TNIK. Taken together, this review hopes to contribute to the in-depth understanding of the function and regulatory mechanism of TNIK, which is of great significance for revealing the role of TNIK in the occurrence and treatment of diseases.

Keywords: Cancers; Neurological disorders; Psychotic disorders; TNIK; TNIK inhibitors.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Differentiation
  • Cell Proliferation / genetics
  • Humans
  • Mental Disorders / drug therapy
  • Mental Disorders / genetics
  • Mental Disorders / metabolism
  • Mental Disorders / therapy
  • Molecular Targeted Therapy
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics
  • Neoplasms* / metabolism
  • Neoplasms* / pathology
  • Neoplasms* / therapy
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism

Substances

  • TNIK protein, human
  • Protein Serine-Threonine Kinases